Firms

Mubadala Capital

Founded

—

Type

Venture capital

Team

No team members on record yet.

Co-investing

B Capital

• Precision Neuroscience$250M · 2026-09-24
• Precision Neuroscience$41M · 2023-01-25

Mirae Asset Capital

• Precision Neuroscience$250M · 2026-09-24
• DewPoint Therapeutics, Inc.$150M · 2022-02-03

3E Bioventures Capital

• DewPoint Therapeutics, Inc.$150M · 2022-02-03

8VC

• Alloy Therapeutics$75M · 2021-04-02

Ackman Oxman Institute

• Precision Neuroscience$250M · 2026-09-24

SHOW MORE

Investments

$250M2026-09-24	Precision Neuroscience	Pershing Square Capital Management, Ackman Oxman Institute, Duquesne Family Office, B Capital, ARK, The Invus Group, LLC, Mubadala Capital, Mirae Asset Capital, Korea Investment Partners, Hitachi Ventures, JSL Health Capital
$41M2023-01-25	Precision Neuroscience	Forepont Capital Partners, Mubadala Capital, Draper Associates, Alumni Ventures, re.Mind Capital, Steadview Capital, B Capital
$150M2022-02-03	DewPoint Therapeutics, Inc.	General Catalyst, 3E Bioventures Capital, NS Investment, Leaps by Bayer, Polaris Partners, Samsara BioCapital, ARCH Venture Partners, Mirae Asset Capital, Maverick Ventures, Mubadala Capital
$75M2021-04-02	Alloy Therapeutics	8VC, Presight Capital, Peter Thiel, Mubadala Capital, Founders Fund, Gaingels, Luma Bio-IT, Alexandria Venture Investments, Ulysses Diversified Holdings

SHOW MORE